ECSP13012650A - Métodos y composiciones para tratar diarrea asociada con vih - Google Patents

Métodos y composiciones para tratar diarrea asociada con vih

Info

Publication number
ECSP13012650A
ECSP13012650A ECSP13012650A ECSP13012650A EC SP13012650 A ECSP13012650 A EC SP13012650A EC SP13012650 A ECSP13012650 A EC SP13012650A EC SP13012650 A ECSP13012650 A EC SP13012650A
Authority
EC
Ecuador
Prior art keywords
diarrhea
methods
hiv
compositions
diarrhea associated
Prior art date
Application number
Other languages
English (en)
Inventor
William Forbes
Enoch Bortey
Steven King
Pravin Chaturvedi
Original Assignee
Salix Pharmaceuticals Ltd
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP13012650(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Salix Pharmaceuticals Ltd, Napo Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Ltd
Publication of ECSP13012650A publication Critical patent/ECSP13012650A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se plantean en la presente métodos para tratar diarrea al administrar a un paciente en necesidad del mismo, un inhibidor de transporte de iones de cloruro en una cantidad suficiente para tratar diarrea. El tratamiento de diarrea incluye el tratamiento de diarrea así como el dolor, molestia abdominal y otros síntomas asociados con diarrea. En una modalidad, el inhibidor de transporte de iones de cloruro es crofelemer.
ECSP13012650 2010-10-31 2013-05-31 Métodos y composiciones para tratar diarrea asociada con vih ECSP13012650A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19

Publications (1)

Publication Number Publication Date
ECSP13012650A true ECSP13012650A (es) 2013-10-31

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012650 ECSP13012650A (es) 2010-10-31 2013-05-31 Métodos y composiciones para tratar diarrea asociada con vih

Country Status (19)

Country Link
US (4) US8962680B2 (es)
EP (1) EP2632550B1 (es)
JP (2) JP6063385B2 (es)
CN (2) CN107595836A (es)
AU (1) AU2011320155B2 (es)
BR (1) BR112013010774A2 (es)
CA (1) CA2816416C (es)
DK (1) DK2632550T3 (es)
EC (1) ECSP13012650A (es)
ES (1) ES2635435T3 (es)
HK (1) HK1249036A1 (es)
HU (1) HUE035393T2 (es)
MX (1) MX348184B (es)
PE (1) PE20140036A1 (es)
PL (1) PL2632550T3 (es)
PT (1) PT2632550T (es)
RU (1) RU2597746C2 (es)
WO (1) WO2012058664A1 (es)
ZA (1) ZA201303136B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007248183B2 (en) 2006-05-01 2013-08-01 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
SI2241318T1 (sl) 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
PT2632550T (pt) 2010-10-31 2017-08-02 Napo Pharmaceuticals Inc Métodos e composições para tratar diarreia associada a vih
MX2015007065A (es) * 2012-12-07 2017-03-01 Napo Pharmaceuticals Inc Metodo y composiciones para tratar diarrea asociada con vih.
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
CA3182864A1 (en) * 2020-06-19 2021-12-23 Lisa A. CONTE Methods and compositions for treating chemotherapy-induced diarrhea
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
ATE430477T1 (de) 1996-10-16 2009-05-15 Napo Pharmaceuticals Inc Enteral-formulierungen von proanthocyanidzusammensetzungen gegen diarrhöe
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2006262275A1 (en) * 2005-06-22 2007-01-04 The Massachusetts Institute Of Technology HIV-1 protease inhibitors, and methods of making and using them
WO2007068383A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
SI2241318T1 (sl) 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
AU2007248183B2 (en) 2006-05-01 2013-08-01 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
EA023814B1 (ru) 2009-08-26 2016-07-29 Гленмарк Фармасьютикалс Лтд. Способ получения полимерных композиций на основе проантоцианидина для фармацевтических форм
JP2013506716A (ja) * 2009-10-06 2013-02-28 ザ レゲンツ オブ ジ ユニヴァーシティ オブ カリフォルニア クロフェレマーなどのプロアントシアニジンオリゴマーを用いて疾患を治療する方法
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
PT2632550T (pt) 2010-10-31 2017-08-02 Napo Pharmaceuticals Inc Métodos e composições para tratar diarreia associada a vih
RU2593014C2 (ru) 2011-01-27 2016-07-27 Гленмарк Фармасьютикалс Лимитед Способ производства проантоцианидиновой полимерной композиции
RU2014124981A (ru) 2011-12-22 2016-02-10 Гленмарк Фармасьютикалс Лимитед Неэнтеросолюбильная фармацевтическая композиция, содержащая крофелемер
MX2015007065A (es) 2012-12-07 2017-03-01 Napo Pharmaceuticals Inc Metodo y composiciones para tratar diarrea asociada con vih.

Also Published As

Publication number Publication date
CA2816416C (en) 2020-02-11
HUE035393T2 (en) 2018-05-02
ZA201303136B (en) 2016-01-27
ES2635435T3 (es) 2017-10-03
HK1249036A1 (zh) 2018-10-26
JP2013540826A (ja) 2013-11-07
MX2013004873A (es) 2013-08-21
AU2011320155B2 (en) 2016-02-25
JP2017019806A (ja) 2017-01-26
RU2597746C2 (ru) 2016-09-20
PE20140036A1 (es) 2014-01-31
US20150190367A1 (en) 2015-07-09
JP6310971B2 (ja) 2018-04-11
US9585868B2 (en) 2017-03-07
JP6063385B2 (ja) 2017-01-18
PL2632550T3 (pl) 2017-10-31
PT2632550T (pt) 2017-08-02
WO2012058664A1 (en) 2012-05-03
AU2011320155A1 (en) 2013-05-09
US20140294903A1 (en) 2014-10-02
US20120184605A1 (en) 2012-07-19
US8962680B2 (en) 2015-02-24
EP2632550B1 (en) 2017-05-03
US20120107370A1 (en) 2012-05-03
CN103370101A (zh) 2013-10-23
CN107595836A (zh) 2018-01-19
BR112013010774A2 (pt) 2017-03-21
RU2013123794A (ru) 2014-12-10
EP2632550A4 (en) 2014-04-23
EP2632550A1 (en) 2013-09-04
MX348184B (es) 2017-06-02
CA2816416A1 (en) 2012-05-03
DK2632550T3 (en) 2017-08-07

Similar Documents

Publication Publication Date Title
ECSP13012650A (es) Métodos y composiciones para tratar diarrea asociada con vih
ECSP15030799A (es) Compuestos sustituidos de pirrolopirimidina, composiciones de los mismos, y métodos de tratamiento con los mismos
CR20140410A (es) Esketamina para el tratamiento de la depresión refractaria al tratamiento o resistente al tratamiento
ECSP12012106A (es) Terapia antiviral
NZ602219A (en) Methods and compositions for treating degos’ disease
MD4577C1 (ro) Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare
EA201201186A1 (ru) ИСПОЛЬЗОВАНИЕ ErbB3 ИНГИБИТОРОВ В ЛЕЧЕНИИ ТРИЖДЫ НЕГАТИВНОГО И БАЗАЛЬНО-ПОДОБНОГО ВИДОВ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ
CR11724A (es) Agente para tratar enfermedades
NI201400112A (es) Tratamiento del cáncer con inhibidores tor cinasa
AR087918A1 (es) Tratamientos combinados que comprenden antagonistas de c-met y antagonistas de b-raf
ECSP13012551A (es) Terapia de combinación para tratar infección por hcv.
BR112014019350A8 (pt) Composição terapêutica estéril, seu uso para tratar diarreia induzida por rotavírus e embalagem
DOP2013000131A (es) Composiciones y métodos para tratar el cáncer usando un inhibidor de pi3k y un inhibidor de mek
MX2015007065A (es) Metodo y composiciones para tratar diarrea asociada con vih.
CO6731081A2 (es) Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol
TR200900879A2 (tr) Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
CO6670518A2 (es) Tratamiento de infecciones de clostridium difícile en pacientes bajo terapia con antibióticos
MY180772A (en) Novel therapeutic mirtazapine combinations for use in pain disorders
CO6771411A2 (es) Metodos y composiciones para tratar diarrea asociada al vih
GT201400071A (es) Combinación terapéutica para el tratamiento de cáncer
BR112022025741A2 (pt) Usos de composições compreendendo crofelemer para tratamento de diarreia induzida por quimioterapia (cid)
EA201491836A1 (ru) Способы лечения рака с использованием ингибитора pi3k и ингибитора mek
AR092169A1 (es) Composicion farmaceutica sinergica adaptada para ser administrable oralmente como antiparasitario y procesos para prepararla
CL2022003634A1 (es) Métodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia.
CR20160116A (es) Método para tratar onicomicosis con hidroxipropil quitasano